Arkolith/Insider Trading/NRIX/Form 4

Ring Christine

Chief Legal OfficerNurix Therapeutics, Inc. (NRIX) · full profile →Form 4 · filed Jun 25, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$581K
Net Open-Market Flow
-$581K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 25, 2026Option exercise(M)13K$7.26$97K27K
Jun 25, 2026Option exercise(M)16K$8.72$136K43K
Jun 25, 2026Sell(S)29K$20.06$581K14K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 25, 2026Option exercise(M)13K—$00
Jun 25, 2026Option exercise(M)16K—$0134K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001817199-26-000022) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML